Novus Therapeutics, Inc. Gains 22.47%
Thu, Oct 29, 2020 at 05:30 PM
Novus Therapeutics, Inc. (NVUS:NASDAQ) soared at $21.42, a gain of 22.5%. On Wed 28 Oct 20, NVUS:NASDAQ hit a New 2-Week High of $17.49. The stock got featured on our News Catalysts scanner on Fri 09 Oct 20 at 03:57 AM in the 'SPLIT' category. From Wed 14 Oct 20, the stock recorded 50.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About Novus Therapeutics, Inc. (NVUS:NASDAQ)
Novus Therapeutics Inc is a pharmaceutical company focusing on the acquisition, development, and commercialization of ear, nose, and throat products. Its technologies have the potential to be developed for multiple ENT indications.
Top 10 Gainers:
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 62.69%
- Polar Power, Inc. (POLA:NASDAQ), 58.8%
- Rekor Systems, Inc. (REKR:NASDAQ), 30.42%
- FBRX (FBRX:NASDAQ), 26.94%
- Pinterest, Inc. (PINS:NYSE), 26.92%
- Inphi Corporation (IPHI:NYSE), 26.7%
- IPHI (IPHI:NASDAQ), 26.7%
- RAVE Restaurant Group, Inc. (RAVE:NASDAQ), 25.47%
- Meta Financial Group, Inc. (CASH:NASDAQ), 25.4%
- Novus Therapeutics, Inc. (NVUS:NASDAQ), 22.47%